Medtronic buys disease-management company for $200M

Medtronic (MDT) acquires closely held Cardiocom, a disease-management and patient-monitoring firm, for $200M.

Cardiocom's products, such as home glucose monitors for diabetics and weight scales, help limit the cost of treating patients with chronic diseases. The market for such equipment is set to be boosted by a new health rule that sanctions hospitals when their patients return within a month of being released. Customers include health insurers.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs